Phase II Trial of Decapeptyl (D-TRP-6), a Potent Luteinizing Hormone-Releasing Hormone Analogue in Untreated Advanced Breast Cancer

American Journal of Clinical Oncology ◽

10.1097/00000421-199610000-00006 ◽

1996 ◽

Vol 19 (5) ◽

pp. 455-458 ◽

Author(s):

E. Garcia-Giralt ◽

P. Beuzeboc ◽

V. Dieras ◽

T. Dorval ◽

M. Jouve ◽

...

Keyword(s):

Breast Cancer ◽

Luteinizing Hormone ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Breast ◽

Hormone Analogue ◽

Luteinizing Hormone Releasing Hormone ◽

Releasing Hormone

Download Full-text

Treatment of pre-menopausal advanced breast cancer with goserelin—a long-acting luteinizing hormone releasing hormone agonist

Anti-Cancer Drugs ◽

10.1097/00001813-199202000-00001 ◽

1992 ◽

Vol 3 (1) ◽

pp. 3-8 ◽

Author(s):

Christina Brambilla ◽

Agustin Escobedo ◽

Rossana Artioli ◽

Maria Jose Lechuga ◽

Marcella Motta

Keyword(s):

Breast Cancer ◽

Luteinizing Hormone ◽

Advanced Breast Cancer ◽

Advanced Breast ◽

Luteinizing Hormone Releasing Hormone ◽

Releasing Hormone ◽

Download Full-text

Phase II trial of pegylated liposomal doxorubicin (Caelyx™) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer

Acta Oncologica ◽

10.1080/02841860600897868 ◽

2007 ◽

Vol 46 (2) ◽

pp. 208-213 ◽

Author(s):

Herbert Ulrich-Pur ◽

Gabriela V. Kornek ◽

Karin Haider ◽

Werner Kwasny ◽

Thomas Payrits ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Trial ◽

Pegylated Liposomal Doxorubicin ◽

Advanced Breast ◽

Pretreated Patients

Download Full-text

Phase-II Trial of Oral Idarubicin (4-Demethoxydaunorubicin) in Advanced Breast Cancer

Oncology Research and Treatment ◽

10.1159/000216014 ◽

1986 ◽

Vol 9 (4) ◽

pp. 236-238 ◽

Author(s):

H.-E. Wander ◽

D. Meyer ◽

P. Schuff-Werner ◽

G.A. Nagel

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Breast

Download Full-text

Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain

Annals of Oncology ◽

10.1093/annonc/mdh048 ◽

2004 ◽

Vol 15 (2) ◽

pp. 201-206 ◽

Author(s):

R. Colomer ◽

A. Llombart-Cussac ◽

A. Lluch ◽

A. Barnadas ◽

B. Ojeda ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Predictive Value ◽

Phase Ii Trial ◽

Extracellular Domain ◽

Advanced Breast

Download Full-text

Phase ii trial of D-Trp-6-LH-RH in advanced breast cancer

Journal of Steroid Biochemistry ◽

10.1016/0022-4731(87)91392-6 ◽

1987 ◽

Vol 28 ◽

pp. 100

Author(s):

G. Mathe ◽

R. Helling ◽

J. Gastlaburu ◽

M.L.. VoVan ◽

G. Prévot ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Breast ◽

Download Full-text

Gemcitabine/Epirubicin/Paclitaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group

Clinical Breast Cancer ◽

10.3816/cbc.2008.n.029 ◽

2008 ◽

Vol 8 (3) ◽

pp. 257-263 ◽

Author(s):

John T. Hamm ◽

John W. Wilson ◽

Priya Rastogi ◽

Barry C. Lembersky ◽

George C. Tseng ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Research Group ◽

Phase Ii Trial ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast

Download Full-text

Results of randomized phase II trial combining Iressa® (gefitinib) and arimidex in women with advanced breast cancer (ABC). EORTC protocol 10021.

10.1158/0008-5472.sabcs-6133 ◽

2009 ◽

Author(s):

L Mauriac ◽

D Cameron ◽

L Dirix ◽

E Blot ◽

M Piccart ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Breast ◽

Randomized Phase Ii

Download Full-text

Phase II trial of exemestane in combination with fulvestrant in postmenopausal women with hormone responsive advanced breast cancer: no evidence of a pharmacokinetic interaction between exemestane and fulvestrant.

10.1158/0008-5472.sabcs-6131 ◽

2009 ◽

Author(s):

E Mrozek ◽

LJ Schaaf ◽

B Ramaswamy ◽

D Shiels ◽

L Houton ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Phase Ii Trial ◽

Pharmacokinetic Interaction ◽

Advanced Breast

Download Full-text

OT2-01-03: Eribulin in Women with Locally Advanced Breast Cancer Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy: A Sarah Cannon Research Institute Phase II Trial.

10.1158/0008-5472.sabcs11-ot2-01-03 ◽

2011 ◽

Author(s):

DA Yardley ◽

NW Peacock ◽

JD Hainsworth ◽

III HA Burris

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Pathologic Complete Response ◽

Complete Response ◽

Advanced Breast

Download Full-text

Abstract P2-16-20: Biomarkers to predict response to the CDK 4/6 inhibitor, palbociclib (PD 0332991) in a single-agent phase II trial in advanced breast cancer

10.1158/0008-5472.sabcs13-p2-16-20 ◽

2013 ◽

Author(s):

AS Clark ◽

P Lal ◽

KS Tan ◽

DF Heitjan ◽

M Feldman ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Single Agent ◽

Advanced Breast

Download Full-text